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Abstract
Background Human African Trypanosomiasis (HAT) is 
caused by two species of  the tsetse fly vectored  protozoan 
hemoflagellates belonging to Trypanosma brucei, namely T.b 
gambiense which predominates in Western Africa and follows 
a chronic disease course and  T.b rhodensiense which is more 
prevalent in Southern and Eastern Africa, Malawi included, 
and follows a more acute and aggressive disease course. 
Previous studies in the Democratic Republic of  Congo, 
Angola, Uganda and Sudan have demonstrated that the 
prevalence rates of  T.b rhodensiense infection have reached 
epidemic proportions. 
Objectives To describe the epidemiology of  Trypanosomiasis 
in Rumphi District over the past ten years.
Methodology A total of  163 records from January 2000 to 
December 2006 were retrospectively studied.
Results There were more males than females (121 vs. 40) 
with the 20 – 29 years age bracket having the highest number 
of  cases (26.3%, n=160). Stage 2 HAT was the commonest 
stage at presentation (58.2%, n=158) with the patients in the 
same being 3.5 times more likely to die than those with stage 
1 HAT. Case fatality rates for late and early stage disease were 
21.5% (n = 92) and 7.2% (n = 66) respectively with 84.6% 
having been cured (n=162). Convulsions were associated 
with fatal disease outcome and the majority of  cases (97.2%, 
n=103) lived within 5 kilometres of  the Vwaza game reserve 
boundary.
Conclusion More men have been infected than women, 
with a high involvement in the 20 – 29 age brackets. A 
dramatic increase with active case finding indicates a high 
under-detection of  the disease with late stage HAT being 
predominant at presentation. Though it has been found that 
cases with late stage disease have an increased likelihood 
of  dying compared to those in early stage HAT, the high 
proportion of  successful treatment indicates that the disease 
still carries a high degree of  favourable outcome with 
treatment. It has also been demonstrated in this study that 
more than 95% of  trypanosomiasis cases live within 5 km 
of  game reserve boundary. Disease interventions should be 
implemented in areas within 5km of  marshland game reserve 
boundary as priority areas.
 
Introduction
Human African Trypanosomiasis (HAT) or sleeping sickness 
is an important but equally neglected tropical disease in 
sub-Saharan Africa with an estimated 60 million people at 
risk in nearly 200 separate active foci from 36 sub-Saharan 
countries1. The location of  endemic foci of  HAT follows the 
distribution of  tsetse flies2. In Malawi, foci areas are in the 
districts of  Rumphi, Nkhotakota, Ntchisi and Kasungu. The 
disease is caused by protozoan hemoflagellates belonging to 
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Trypanosoma brucei with two species causing distinct disease 
patterns in humans namely Trypanosma brucei gambiense and 
Trypanosma brucei rhodensiense 1. T.b gambiense is found in central, 
west and some parts of  eastern Africa, whereas T.b rhodesiense 
is found in southern and eastern Africa1. T.b rhodensiense 
infection is usually acute, causing severe symptoms and 
death within a few days or weeks. However, studies in Malawi 
have shown T.b rhodensiense with a chronic disease profile3. 
T.b gambiense infections tend to progress more slowly (over 
several years) and causes less severe symptoms1. 
Human infection occurs sporadically in individuals who 
come into contact with the zoonotic cycle such as poachers, 
hunters, firewood collectors and tourists4.  Inoculation 
of  the protozoa by the vector (Glossina sp) into the blood 
stream is followed by an initial stage of  proliferation at the 
site of  the bite, causing local inflammation (chancre) with 
subsequent invasion of  the hemolymphatic system marking 
what is known as the early stage HAT, also known as stage 
1 HAT. Concomitant involvement of  the central nervous 
system leads to meningocephalitic stage of  the disease, 
also referred to as late stage or stage 2 HAT. Without 
treatment, the disease progresses to coma and death3. Stage 
1 is treated with suramin, but stage 2 can only be treated 
with melarsoprol, a toxic arsenic derivative that is associated 
with the development of  a severe post-treatment reactive 
encephalopathy (PTRE)5. This severe adverse reaction can 
occur in up to 10% of  cases 6,7, and may be fatal in 50% of  
the cases8.
HAT has been described as a major public health problem 
in sub-Saharan Africa, where it affects mainly the rural poor 
populations. The most recent prevalence estimates from the 
World Health Organization are 50,000-70,000 cases, based 
on a total number of  17,500 new cases reported per year 
in Africa9. The disease has been reported to have reached 
epidemic proportions in four countries, with a prevalence of  
over 20% in some areas of: Sudan, Uganda, the Democratic 
Republic of  Congo, and Angola4,10,11,12. It is well appreciated 
that cases tend to cluster in close proximity to animal 
reservoirs such as game parks. Studies on the effect of  
distance to health care in relation to stage of  presentation 
have previously been carried out and have shown that the 
closer the patient lives to the reporting health facility, the 
greater the likelihood to that they will be detected with the 
early stage of  infection13. It has also been demonstrated that 
the prognosis of  late stage disease is poorer than in early 
stage disease14.
WHO estimates that current HAT control activities reach 
only 10% of  persons at risk15. With the results from 
previous studies in other countries suggesting resurgences 
and epidemics of  HAT, it is important to describe the local 
epidemiology of  HAT in order to estimate the burden 
of  disease attributable to HAT in Malawi and to target 
interventions for the communities at risk. This study 
was therefore designed to describe the epidemiology of  
HAT in Rumphi District which is one of  the recognized 
Trypanosomiasis rhodensiense endemic areas in Malawi.
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Methods
This was a retrospective study which reviewed hospital 
records from the laboratory and registry offi ces, of  
Trypanosomiasis cases from January 1997 to December 2006 
at Rumphi District Hospital, which is located in the northern 
Region of  Malawi, where Vwaza game reserve and Nyika 
National Parks are located. The populaces of  the district are 
mainly subsistence farmers and tobacco growing is a major 
agricultural activity. 
Clinical records of  all confi rmed cases of  Trypanosomiasis 
that were recorded at the district hospital were retrieved 
for analysis. In all the cases, blood and cerebrospinal fl uid 
(CSF) samples were taken for diagnosing and staging of  
Trypanosomiasis infection. The diagnosis of  Trypanosomiasis 
infection was confi rmed by demonstration of  parasites in 
the blood or CSF. The presence of  parasites in CSF denoted 
stage 2 and presence of  parasites in the blood only denoted 
stage 1 infection. 
Data Collection
Data on patient age, gender, village of  residence, stage of  
disease at presentation and disease outcome was extracted 
from clinical records and double entered into a Microsoft 
Access database. Geographical coordinates for villages of  
residence for all the cases were collected using a portable 
Global Positioning System (Garmin etrex, Garmin 
International, Inc USA © 2004 Garmin Ltd).
Data Analysis
Analysis was done using Intercooled STATA version 9.0 
(StataCorp LP, 4905 Lakeway Drive, College Station, TX 
77845 USA) and maps to depict spatial characteristics of  
interest in the study were created in ArcView GIS Version 
3.1 (ArcView GIS Version 3.1 © 1992-1998, Environmental 
Systems Research Institute, Inc). Graphs were produced 
using Microsoft Excel software. 
The associations between signs and symptoms with stage 
of  presentation and disease outcome were tested using 
the Pearson Chi-Square test or the Fisher’s Exact test were 
appropriate at the 5% level of  signifi cance. In order to 
examine the relationship of  spatial distribution of  cases and 
disease stage at presentation with respect to distance from 
the treating unit, the Mantel-Haenszel χ2 test was used. 
Logistic regression was used to assess the factors associated 
with the odds of  dying from Trypanosomiasis.  
Ethical Consideration
Ethical approval and oversight was granted by the College of  
Medicine Research and Ethics Committee (COMREC). 
Results
Demographic characteristics of Trypanosomiasis 
cases
In this study, 163 records of  confi rmed Trypanosomiasis 
cases occurring over a period of  7 years were available. The 
age and sex distribution of  the cases is shown in Figure 1. Of  
note, there were more males than females (3:1). The overall 
median age was 25 years (range 0 – 70 years) with adults 
accounting for 67.3% of  the cases. 
Temporal trends in the number of Trypanosomiasis 
cases 
The trends in the number of  confi rmed cases, being attended 
to by the hospital, showed a general rise over the 7 year period 
under study, with a marked increase in 2003 (Figure 2). 
 
Clinical characteristics of Trypanosomiasis cases
There was a predominance of  Stage 2 HAT cases at 
presentation, accounting for 58.2% of  the cases.  Treatment 
outcomes were considerably good despite the fact that most 
of  the cases presented in the late stage of  disease. In this 
cohort of  patients, mortality was 15.4% with 80% of  the 
Figure 1:  Age and sex distribution of HAT cases by sex at Rumphi District Hospital (2000 – 2006) 
Epidemiology of Trypanosomiasis in Rumphi district   24
MMJ 21(1) 2009 www.mmj.medcol.mw
deaths having had late stage disease. Case fatality rates for 
late and early stage disease were 21.5% (n = 92) and 7.2% 
(n = 66) respectively with 84.6% having been cured (n=162. 
Fever was the most reported symptom in both stages (Early 
stage = 50%; Late stage = 40.7%). However, there was no 
statistically significant difference in the proportion of  patients 
with fever as a symptom between the two clinical stages and 
no associations were found between any of  the remaining 
documented symptoms or signs with stage at presentation 
(Table 1). 
Factors associated with outcome
Treatment outcome was significantly associated with stage 
at presentation (p=0.01) and presence of  convulsions 
(p=0.005). Multivaraite analyses indicated that after adjusting 
for the presence of  convulsions, individuals who presented 
with Stage 2 HAT  were more likely to die than those with 
Stage 1 HAT (odds ratio (OR) = 3.51,  95% Confidence 
Interval (CI)  1.24  - 9.88). Fever was not associated with 
either outcome (45.5% amongst those that survived, 50% in 
those that died, (Table 2).
Spatial distribution of Trypanosomiasis cases
Most of  the cases, 97.2 % (n = 103) came from within 
5km of  the game reserve boundary (Figure 3). The vast 
majority of  cases were clustered along the Vwaza Game 
Reserve boundary compared to Nyika Game Reserve as 
demonstrated by Geo-referencing (Figure 4). We did not 
find an association between distance from diagnostic facility 
and stage at presentation (p-value = 0.60) or outcome (p-
value = 0.32).  
Discussion
This data has shown that more men are infected with 
Trypanosomiasis in Rumphi district. This could be attributed 
to greater exposure to the parasite by men because of   the 
nature of  the activities which they engage in which include 
poaching, honey gathering and encroachment into the game 
reserve to clear land for tobacco farming, which is a major 
economic activity in this area. It is within the same vein that 
the greater proportions of  cases are adults owing to activities 
that bring them into contact with the infected vectors. 
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Figure 3: Distance of villages of residence of trypanosomiasis cases from game reserve boundary (2000 – 2006)
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number of  cases of  Trypanosomiasis over the 7 year period 
understudy. However, there was a marked increase that was 
noted in 2003 by 600%. This could be attributed to active 
case finding that was done that year with support from the 
East African Network for Trypanosomiasis (EANET) as 
part of  a Trypanosomiasis surveillance programme. Such 
a change concurs well with findings from a previous study 
conducted in Uganda of  under-detection of  T.b. rhodensiense 
infection16.
With more than 50% of  the cases having been diagnosed 
with late stage disease, the study findings run in tandem 
with findings of  a study conducted in Uganda14 in which 
approximately half  the Trypanosomiasis  patients presented 
with late stage disease. This finding could be due to weak 
surveillance. It could also be attributed to possible causative 
factors described as either patient factors or the health 
system. Some of  these factors could include poverty of  
endemic countries, poverty of  patients and low sensitivity 
of  the diagnostic techniques13.  In Rumphi, distance from 
the health facility does not seem to influence stage at 
presentation. As such, other parameters could be responsible 
for this observation, such as patient perceptions toward the 
seriousness of  the disease, quality of  health care or access to 
health education. These parameters were not assessed in the 
current study. 
There was a greater chance of  dying with late stage disease 
than early stage. This observation is in agreement with 
observations from a previous study that showed that the 
prognosis of  late stage sleeping sickness presentation is 
significantly poorer that in the one in the early stage of  
the disease14. There were marked successful outcomes in 
treatment. These outcomes are likely due to the efficacy of  
the treatment and management at the hospital. Fever was 
the most reported symptom in both stage 1 and 2 HAT. 
However, there was no statistically significant association 
to warrant it as a clinical predictor of  disease stage. There 
was a significant association between convulsions and fatal 
outcome. As such, convulsions could serve as a prognostic 
indicator of  HAT. 
The vast majority of  cases were in close proximity to Vwaza 
game reserve which is a marsh land compared to Nyika game 
reserve which is mountain ecology. Such spatial distribution 
of  the cases agrees with observations in a study done in 
200516 where proximity to swampland was predictive of  T.b 
rhodensiense infection. This observation could be attributed to 
an ecology dependant factor for the reservoir vector which 
is favoured by marsh land. This however, was not assessed in 
the current study.
The greatest limitation encountered in the study was the 
unavailability of  records dating from 1997 to 1999. Other 
limitations included the poor recording of  clinical parameters 
with lack of  specific definitions for signs and symptoms and 
the inability to trace the areas of  residence of  some of  the 
cases. Despite the limitations, this study managed to attain a 
satisfactory number of  cases as well as having clear definitions 
for disease stage at presentation. Demographic and clinical 
outcome data was clearly documented from the available 
records. Additionally, this is the first retrospective study that 
has described in detail the epidemiology of  Trypanosomiasis 
in a recognized endemic area in Malawi. 
 
Conclusion
This study indicates that over the past seven years, more men 
have been infected than women, with a high involvement in 
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Spatial Distribution of HAT Cases
Figure 4: Spatial distribution of Trypanosomiasis cases with respect to Rumphi District Hospital and game reserve boundary. 
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finding indicates a high under-detection of  the disease with 
late stage HAT being predominant at presentation. Though 
it has been found that cases with late stage disease have an 
increased likelihood of  dying compared to those in early stage 
HAT, the high proportion of  successful treatment indicates 
that the disease still carries a high degree of  favourable 
outcome with treatment. It has also been demonstrated in 
this study that more than 95% of  trypanosomiasis cases live 
within 5 km of  game reserve boundary.
In light of  the findings in this study, it is recommended 
that disease interventions should be preferentially targeted 
to communities who live within 5 km of  marsh land game 
reserve boundary. There is also a need to implement 
interventions that would lead to earlier presentation to the 
health facility in order to reduce the marked proportion of  
late stage presentations which are associated with more than 
a threefold chance of  dying. Such interventions could include 
increased community sensitization campaigns and stronger 
disease surveillance. 
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Essay Competition - Young Voices in Research for 
Health
For the fourth time, the Global Forum and The Lancet invite young researchers and leaders of  tomorrow to submit an 
essay to the popular competition “Young Voices in Research for Health”: Innovating for the health of  all.
The deadline for receipt of  entries is 3 May 2009.
Who can participate?
If  you are a young professional (under 30) working on or interested in the broad spectrum of  research for health, 
please feel free to submit your original, provocative, idealistic and passionate ideas on this year’s theme, taking estab-
lished practices to task in a constructive fashion. You will find the participation guidelines here: http://www.globalfo-
rumhealth.org/shlinks/yvhr2009.php
What is the theme?
This year’s competition focuses on “Innovating for the health of  all”. “Innovation” encompasses the entire process 
from the generation of  new ideas, to their transformation into something useful, to their implementation. Innovation 
for health includes the development of  new and more cost-effective services, products, methods, management practices 
and policies to improve health outcomes. It involves both social and technological innovation.
What are the prizes? 
The 40 most outstanding essays will be published in an anthology and the authors are featured one by one on the Glo-
bal Forum’s home page throughout the year. From these, five or six winners from different geographical regions will 
be invited to Forum 2009, with all expenses paid (Havana, Cuba, from 16 to 20 November). http://www.globalforum-
health.org/shlinks/f2009.php
Deadline: 3 May 2009
You can submit your essay here: http://www.globalforumhealth.org/shlinks/yvhr2009.php
(in English, French or Spanish) and/or help spread the word by forwarding this message.
